← All trials
NCT06892548
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 2, 2025
- Primary completion
- Aug 31, 2027
- Completion date
- Jun 30, 2031
- First posted
- Mar 24, 2025
- Last posted
- Nov 12, 2025
- Enrollment
- 594
- Arms / groups
- 8 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BiontechLead sponsor
- BiontechOfficial
- BiotheusCollaborator
- DualityBio Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.